Based on the Guidelines for Clinical Diagnosis and Treatment of Advanced Breast Cancer in China (2020 edition), the China Advanced Breast Cancer Guideline Panel updated the 2022 edition of this guideline under the guidance of the Breast Cancer Expert Committee of National Cancer Quality Control ...
乳腺癌(Breast cancer)(下) 5 治疗 5.1 方法注意事项 手术被认为是早期乳腺癌的主要治疗方法;许多患者通过单纯手术治愈。乳腺癌手术的目的包括完整切除原发肿瘤、切缘阴性以降低局部复发的风险、肿瘤及腋窝淋巴结(ALNs)病理分期以提供必要的预后信息。乳腺癌辅助治疗用于治疗微转移病灶(如逃出乳腺和区域淋巴结但还没有...
NCCN Guidelines For Breast Cancer Updated; Bevacizumab Recommendation Affirmed
The updates to management of early invasive breast cancer in 2016 are minor but have important treatment implications for patients. The NCCN Guidelines Panel for Breast Cancer has added endocrine therapy to its recommendations for the neoadjuvant treatment of patients with ER-rich tumors. For women ...
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, infla...
William J. Gradishar, MD, highlights the inclusion of abemaciclib in the NCCN Guidelines for select high-risk early-stage breast cancer patients, anticipates the potential for ribociclib to secure a similar guideline position, and emphasizes the importan
NCCNCLINICALPRACTICEGUIDELINESINONCOLOGYBreastCancer,Version3.2020WilliamJ.Gradishar,MD1,*;BenjaminO.Anderson,MD2,*;J..
These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and dis...
During a Case-Based Roundtable® event, Ian Krop, MD, and participants discussed how the outcomes of the DESTINY-Breast03 and other trials impact treatment of metastatic HER2-positive breast cancer in the second article of a 2-part series. FDA Fast Tracks Emiltatug Ledadotin in Advanced/Met...
National Comprehensive Cancer Network. NCCN Guidelines: Breast Cancer. Version 4.2022. www.nccn.org/guidelines/guidelines-detail?category=1&id=1419 Beverly Moy, RB Rumble, Lisa AC, et al. Chemotherapy and Targeted Therapy for Human Epiderma...